[1] 晏峰,徐伟珍,揭伟霞,等.肝硬化患者血清血管紧张素转化酶与C反应蛋白的变化分析.检验医学,2013,28:1073-1076.
[2] Shahid SM, Fatima SN, Mahboob T. Angiotensin converting enzyme (ACE) gene expression in experimentally induced liver cirrhosis in rats. Pak J Pharm Sci, 2013, 26: 853-857.
[3] Lee JY, Lee JH, Kim DK, et al. C-reactive protein as a prognostic factor for mortality in pneumonia patients with liver cirrhosis. Hepatogastroenterol, 2014, 61:1331-1338.
[4] 雷旭艳.血清超敏C反应蛋白在不同肝病患者中的表达与意义.齐齐哈尔医学院学报,2013,34:2389-2390.
[5] Kim SR, Kondo F, Otono Y, et al. Serum amyloid A and C‐reactive protein positive nodule in alcoholic liver cirrhosis, hard to make definite diagnosis.Hepatol Res, 2014, 44:584-590.
[6] Lin KH, Wong FL, Wu MS, et al. Serum procalcitonin and C-reactive protein levels as markers of bacterial infection in patients with liver cirrhosis: a systematic review and meta-analysis. Diagn Microbil Infec Dis, 2014, 80:72-78.
[7] 晏峰,徐伟珍,揭伟霞,等.肝硬化患者血清血管紧张素转化酶和C反应蛋白水平与肝损害程度关系分析.浙江医学,2012,34:1857-1858,1860.
[8] Di Martino V, Coutris C, Cervoni JP, et al. Prognostic value of C-reactive protein levels in patients with cirrhosis. Liver Transplant, 2015, 21: 753-760.
[9] 朱凌云,简斐,童宁. 缬沙坦对肝纤维化患者肝纤维化程度的影响. 中国临床药理学杂志,2014,30:176-178.
[10] 马丽娜,刘晓彦,胡彦超,等.血清超敏C反应蛋白在慢性乙型肝炎进展中的意义.中华肝脏病杂志,2015,23:498-501.
[11] Alempijevic′ T, Sokic′-Milutinovic′ A, Toncev L, et al. Primary biliary cirrhosis and hepatic sarcoidosis: a case report. Vojnosanit Pregl, 2014, 71:83-86.
[12] Grace JA, Klein S, Herath CB, et al. Activation of the MAS receptor by angiotensin-(1-7) in the renin-angiotensin system mediates mesenteric vasodilatation in cirrhosis. Gastroenterology, 2013, 145:874-884.
[13] 张龙琪,王伟洪.肝硬化患者血管紧张素转化酶测定的临床意义.中国初级卫生保健,2011,25:99-100.
[14] Fontana M, Barison A, Botto N, et al. CMR-verified interstitial myocardial fibrosis as a marker of subclinical cardiac involvement in LMNA mutation carriers. JACC-Cardiovasc Imag, 2013, 6:124-126.
[15] Zhang W, Xu YZ, Liu B, et al. Pioglitazone upregulates angiotensin converting enzyme 2 expression in insulin-sensitive tissues in rats with high-fat diet-induced nonalcoholic steatohepatitis. Sci World J, 2014, 2014:603409. |
